stars 1 stars 2 stars 3

Oria Bioscience is a pioneering French TechBio company expert in generating organelles. We deliver high-quality, intact living organelles, surrounded by their therapeutic membrane targets. For the first time, organelles are being distributed globally and are fully compatible with high-throughput screening campaigns and drug development efforts. Thanks to our microfluidics technology, we supply pharmaceutical laboratories and CROs with purified organelles (lysosomes, mitochondria, and endoplasmic reticulum). Working directly with organelles improves efficacy results, reduces attrition rates in clinical phases, accelerates Hit-to-Lead and Lead Optimization phases, and minimizes your carbon footprint by reducing resources used. Oria’s team brings together over 50 years of expertise in organelles and microfluidics, dedicated to delivering organelles worldwide to meet drug discovery needs. We are making organelles as accessible as cells, driving innovation across all health sectors.

Website https://www.oriabs.com
Employees 21 (11 on RocketReach)
Founded 2024
Address 8, Rue Méchain, Paris, Île-de-France 75014, FR
Industry Biotechnology Research

Oria Bioscience Questions

Marine Moutia is the Chief Operating Officer and Co-founder of Oria Bioscience.

11 people are employed at Oria Bioscience.

Oria Bioscience is based in Paris, Île-de-France.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users